Farah
coach used prohibited drug infusions, says newspaper
Send a link to a friend
[February 27, 2017]
(Reuters) - Alberto Salazar, the
coach of Britain's Olympic champion Mo Farah, has been accused of
using prohibited infusions of supplements to improve the performance
of his runners, the Sunday Times reported citing a leaked United
States Anti-Doping Agency (USADA) report.
The British newspaper said the 2016 report also accused Salazar of
abusing prescription medicines for his athletes at the Nike training
center in Oregon.
Attempts by Reuters to reach Salazar for comment were unsuccessful.
Salazar issued a lengthy and detailed denial of similar allegations
in 2015.
Farah said in a statement on Sunday that he was "a clean athlete who
has never broken the rules in regards to substances, methods or
dosages."
Farah, who last year became only the second man to retain the
Olympic 5,000 and 10,000-metre titles, accused the newspaper of
using his profile to make "the story more interesting".
"If USADA or any other anti-doping body has evidence of wrongdoing
they should publish it and take action rather than allow the media
to be judge and jury," he added.
The Sunday Times said the USADA report had been leaked by the 'Fancy
Bears' hacking group which has previously leaked medical and
doping-related documents.
The newspaper said that Farah and other athletes coached by Salazar
were given infusions of a research supplement based on the chemical
L-carnitine and that one who was given a high dosage said that it
was as effective as illegal blood doping.
It said Salazar also emailed disgraced cyclist Lance Armstrong
touting the benefits of L-carnitine.
L-carnitine is not a banned substance for athletes but infusions of
more than 50ml in the space of six hours are prohibited, the
newspaper added.
USADA on Saturday confirmed to Reuters the document cited by the
Sunday Times appeared to have been leaked but would not comment on
the report's conclusions or any accusations against Salazar.
"USADA can confirm that it has prepared a report in response to a
subpoena from a state medical licensing body regarding care given by
a physician to athletes associated with the Nike Oregon Project,"
USADA Communications Manager Ryan Madden said in an email to
Reuters.
[to top of second column] |
Mo Farah of Great Britain jobs past coach Alberto Salazar in the
Bird's Nest Stadium at the Wold Athletics Championships in Beijing,
China, August 21, 2015. REUTERS/Lucy Nicholson/Files
"It appears that a draft of this report was leaked to
the Sunday Times by the Russian state-affiliated hacker group known
as Fancy Bears.
"We understand that the licensing body is still deciding its case
and as we continue to investigate whether anti-doping rules were
broken, no further comment will be made at this time."
Salazar, a Cuban-born American marathon runner who has worked with
Farah since 2011, was accused of violating anti-doping rules in a
BBC documentary in 2015, including allegations he had given 2012
Olympic 10,000m silver medalist Galen Rupp the banned anabolic
steroid testosterone.
Farah was exonerated by UK Athletics who found no impropriety on his
part after receiving the initial findings of a review into his
relationship with Salazar.
The latest Sunday Times article says that, according to the leaked
document, Salazar took "egregious risks" and abused prescription
rules by persuading Farah to take potentially dangerous doses of
permitted vitamin D prescription drugs believing it would boost his
performance through increased testosterone levels.
Farah's British doctors intervened because they were concerned about
the effects on his health, the paper said, citing the leaked USADA
report.
The Fancy Bear hackers have previously published data on athletes
gained from the World Anti-Doping Agency administration and
management system via an account for the Rio Games.
(Reporting by Simon Evans in Miami; Additional reporting by Gene
Cherry and Toby Davis; Editing by Andrew Both/Keith Weir) [© 2017 Thomson Reuters. All
rights reserved.]
Copyright 2017 Reuters. All rights
reserved. This material may not be published, broadcast, rewritten
or redistributed. |